High Throughput, Low Cost SARS-CoV-2 Detection
Increasing laboratory efficiency with scalable solutions
United States: For in vitro diagnostic use – FDA Emergency Use Authorization (EUA).
Europe: CE-IVD marked and intended for in vitro diagnostic use in Europe.
The MassARRAY® SARS-CoV-2 Panel from Agena Bioscience® enables laboratories to meet the demands of the COVID-19 pandemic with a high-throughput and low-cost assay for the detection of the novel coronavirus, SARS-CoV-2.
The MassARRAY SARS-CoV-2 Panel is now available, with:
- ACCURATE DETECTION: Five SARS-CoV-2 assays multiplexed into a single reaction, targeting the nucleocapsid (N) gene and ORF1ab region.
- SCALABLE THROUGHPUT: Process up to thousands of samples per day with a single instrument.
- LOW COST: Low-cost reagents and automated results reporting saves lab resources.
- RELIABLE SUPPLY: Overcome instrument and reagent shortages with a reliable supply.
Panel Resources